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Abstract
Objective: To determine the incidence of bronchopulmonary dysplasia, to identify maternal and
neonatal factors associated with the disease, and to determine the correlation between bronchopulmonary
dysplasia and the progress of newborns.
Methods: Data were prospectively collected on 153 infants born in Campinas (state of São Paulo,
Brazil) from September 2000 to April 2002 weighing less than 1,500 g and treated at the University
Hospital. The ratio of incidence rates with 95% CI, Breslow-Cox regression, Student’s t test, linear
regression and the Fisher’s exact test were utilized.
Results: Among the 124 babies who survived until 28 days of age, 33 (26.6%) developed
bronchopulmonary dysplasia. Birthweight < 1,000 g (5.6; 95% CI 3.0, 10.4) and gestational age < 30 weeks
(4.0; 95% CI 2.1, 7.2) were correlated with increased incidence of bronchopulmonary dysplasia. Breslow-
Cox regression showed that other factors including gender, Apgar score, hyaline membrane disease,
antenatal steroid therapy, pregnancy-induced hypertension, delivery route and maternal age were not
associated with bronchopulmonary dysplasia. Mean duration of hospitalization and ventilator therapy in
newborns with and without bronchopulmonary dysplasia was 78.8 days (SD = 26.67) vs. 43.0 days (SD
= 14.49) (p < 0.01) and 27.2 days (SD = 21.26) vs. 3.7 days (SD = 3.02) (p < 0.01), respectively. Mean
weight gain per day was lower in newborns with bronchopulmonary dysplasia (p < 0.01). Mortality in
newborns with bronchopulmonary dysplasia was 21% (p < 0.00005).
Conclusions: Gestational age and birthweight were inversely proportional to incidence of
bronchopulmonary dysplasia. After the onset of bronchopulmonary dysplasia, newborns with the disorder
required longer periods of ventilator therapy and hospitalization, and presented inadequate weight gain and
higher mortality rates than newborns without bronchopulmonary dysplasia.
J Pediatr (Rio J). 2003;79(6):550-6: Bronchopulmonary dysplasia; prematurity; very low birth weight
newborns; chronic lung disease of prematurity.
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Introduction
Recent advances in perinatal care have improved the
survival of very low birth weight infants (VLBWI). The
development of new treatments over the last few decades
has reduced mortality, but their efficacy in reducing the
occurrence of bronchopulmonary dysplasia (BPD) remain
controversial.1 The incidence of BPD varies in published
studies from 23 to 83%.2 This can be explained by the
acute respiratory insufficiency of the populations studied,
the type of care afforded the newborn (NB), or the
diagnostic criteria employed.
Bronchopulmonary dysplasia is the most common
obstructive lung disease among premature NBs. Its
incidence increases as birth weight (BW) and gestational
age (GA) decrease.3-6 Northway et al.7 and later Bancalari
et al.8 described BPD defining the disease according to
oxygen requirements at 28 days.
Bronchopulmonary dysplasia is a disease whose
etiology has not yet been fully established, being the
result of multiple factors that act on the immature
pulmonary system, subject to aggression from many
different sources and, at the same time, having defense
mechanisms that have not yet developed.9 In contrast,
the only unanimous consensus is that pulmonary
immaturity is a risk factor for the development of BPD.
In addition to prematurity, low BW, male sex, low
Apgar scores and Hyaline membrane disease (HMD)10-12
have all been associated with BPD. In contrast, the use of
prenatal corticoids has been associated with a reduced
BPD incidence.13
As BPD is associated with increased morbidity and
mortality during the neonatal period and is also often the
cause of prolonged hospitalization with serious social
and economic consequences,14 deeper understanding of
the disease will contribute to future preventative measures
aimed at reducing i ts incidence, minimizing
complications, diminishing hospital costs and improve
infant health. This research aimed to discover the
incidence of bronchopulmonary dysplasia among very
low birth weight infants, to assess the maternal and
neonatal factors that are associated with the disease and
to determine the correlation between bronchopulmonary
dysplasia and the progress of these infants.
Methods
A prospective study was performed of a cohort of 153
NBs, treated at the Center for Integral Women’s Health
Care (CAISM- Centro de Atenção Integral à Saúde da
Mulher) at the Universidade Estadual de Campinas
(UNICAMP). All infants with a BW of less than 1,500 g,
born live during the period between September 2000 and
April 2002. Infants with major malformations or
chromosomal syndromes were excluded. Infants that
died or were transferred to other sectors with resultant
loss of monitoring before the 28th day were not included
in the analysis as not satisfying the time period established
for the diagnostic criteria employed.
The clinical diagnosis of BPD was defined as the
need for supplementary oxygen at 28 days in order to
maintain arterial oxygen pressure (PaO2) > 50 mmHg
8 in
association with consistent radiological findings. Chest
x-ray was used between the 4th and 5th weeks of life for
infants dependant upon oxygen. Radiographs were
evaluated by a neonatologist and a pediatric radiologist.
Variables related to the mother (age, number of
consultations, prenatal care, hypertensive disorders of
pregnancy, type of delivery and prenatal corticoid used),
to the infant (BW, GA, Apgar score, type of respiratory
disorder, sex, normality of weight/age ratio) and to the
progress of the infant (weight/day gain, period of
hospitalization, period of mechanical ventilation and
mortality) were all analyzed.
Maternal age was banded into < 19 and > 19 years.
These age bands were chosen for study based on their
difference as representing a group of adolescents
compared with a group of mature women.15 For prenatal
care the study employed a cut-off point of: < 3 and > three
consultations. Prenatal corticoid use was defined as at
least one corticoid dose at least 24 hours at most seven
days prepartum.
Gestational age was established for all NB by the
method established by Ballard et al.16 and confirmed by
reference to last menstrual cycle. In cases in which the
clinical examination did not agree with the date of
amenorrhea by more than two weeks, amenorrhea was
used. The normality of weight/age was classified in
accordance with the Battaglia & Lubchenco growth
curves.17 Apgar scores were grouped into two categories:
NBs with an Apgar < 7 and NBs with an Apgar > 7.11
Hypertensive disorders of pregnancy were defined as
arterial pressure levels of 140/90 mmHg or more after
the 20th week of gestation. The type of respiratory
disease was taken to be the acute pulmonary disease that
the NB developed during its first 72 hours of life. The
criteria for HMD diagnosis included increased oxygen
dependency during the first 24 hours confirmed by
radiological patterns typical of diffuse “ground-glass”
infiltration and with air bronchograms.
Weight/day gain was defined as the average obtained
by subtracting birth weight from weight on discharge and
dividing the result by the number of days of
hospitalization. Mechanical ventilation duration was
measured in days for NB that used neonatal respirators
with any combination of parameters. Incomplete days
were categorized as follows: 0 < x < 6h = 0.25 day; 6 <
x < 12h = 0.5 day; 12 < x < 18h = 0.75 day; 18 < x < 24h
= 1 day. Bronchopulmonary dysplasia was considered an
independent variable in analyzing the infant progress
variables.
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All of the NB were maintained in incubators under a
radiant heat source. Surfactant (Survanta®) was used as
a salvation therapy for HMD in cases where ventilated
NBs required oxygen supplementation at FiO2 levels
greater than 40% with PaO2 < 50 mmHg or PaCO2 > 55
mmHg and x-rays were typical of HMD. Ventilation
therapy respirators were pressure-limited, time-cycled
and continuous flow (Sechrist Model IV-100B, Sechrist
and Inter 3, Intermed). Mechanical ventilation was
indicated for NBs with inadequate gas exchange,
hypercapnia (PaCO2 > 55 mmHg) and hypoxemia (PaO2
< 50 mmHg) when on supplementary oxygen. Ventilators
were adjusted to maintain PaO2 > 50 mmHg, PaCO2 < 55
mmHg and oxygen saturation, by pulse oximetry, between
87% and 96%.
Infants that developed BPD were classified according
to the severity of the disease as mild, moderate and severe,
according to criteria formulated by Jobe & Bancalari.18
Sample size was calculated as 103 VLBWI for an α of
5% and a ß of 20%. The study was approved by the
Committee for Ethics in Research of the Medical Sciences
Faculty at UNICAMP.
For each infant a form was filled out that had been
designed for the study. Data was entered into a database
using Epi-Info 6.0. Data was input twice in order to
perform a consistency test and any inconsistencies
corrected.
For the statistical analysis BPD incidence rates (IR)
were calculated according to maternal and neonatal
variables. For each of these variables, IR were compared
between categories to give incidence rate ratios (IRR)
with 95% confidence intervals (CI). The IRR for each
variable was adjusted for BW, GA and, when necessary,
according to HDP and type of delivery, by means of the
Breslow-Cox regression model.19 The Student t test was
used for continuous variables, with a 5% significance
level (p < 0.05). These variables were adjusted for BW
and GA via a linear regression model.20 Fisher’s exact
test was used to compare mortality between groups. All
statistical analysis was performed using the software
SAS, version 8.2.
Results
The study began with 153 NB of whom 29 died before
the 28th day of life and were excluded from the analysis.
The causes of death were heart disease (three), otitis
media (four), supra-renal failure (one), pulmonary
hemorrhage (four), extreme prematurity (two),
cardiogenic shock (one) and 14 cases of sepsis.
Average weight and standard deviation (SD) and
average GA (SD) of the NB that died were 833.8 (253.3
grams) and 27.9 (2.3 weeks) respectively. Of the 124 NB
that survived, 33 (26.6%) developed BPD. All of the NB
that developed BPD had gestational ages of less than 32
weeks. Four NB (12.1%) developed mild BPD, 16
(48.5%) moderate and 13 (39.4%) severe.
Average BW and GA were significantly lower for the
group with BPD compared with those without the disease:
913.3±199.4 as against 1.242.1±181.6 g and 28.9±2.0
against 31.8±2.0 weeks, respectively. Table 1 shows that
GA and BW are strongly and independently associated with
developing BPD.
Data on sex, intrauterine growth and first minute
Apgar score were not associated with BPD incidence.
The fifth minute Apgar score showed an association with
increased BPD incidence which did not remain after
adjustment for BW and GA. Hyaline membrane disease
was the primary respiratory disorder in 71.4% of the NB
that developed BPD, giving a significantly higher gross
IRR amongst these NB. However, when the confounding
variables, BW and GA were controlled, the adjusted IRR
showed that HMD did not directly influence the incidence
of BPD (Table 1).
The results in Table 2 indicate that the BPD IR is
greater among NB whose mothers did not receive
corticoid, with a gross IRR that double for untreated
mothers. However, when this variable was adjusted for
BW and GA, while the adjusted IRR was still higher for
mothers that hadn’t received corticoid, this difference
was no longer statistically significant. It can be observed
that HDP was initially a variable statistically correlated
with BPD, presenting gross BPD IR and IRR significantly
lower for NB whose mothers presented the disease.
However, the fact that the mother presented HDP taken
as a factor independently of BW and GA in the NB
revealed an adjusted IRR below the 5% significance
level. All 8 HDP cases that developed BPD were the
children of mothers that presented preeclampsia. In terms
of type of delivery, a gross IRR of 0.4 demonstrated a
protective effect for NB whose mothers underwent
caesarians. However, when the confounding variables,
HDP, BW and GA were controlled, the adjusted BPD
IRR differences were not significant. The effect of
maternal age was not sustained when the variables BW,
GA, HDP and type of delivery were controlled. Similarly,
prenatal care and number of consultations did not
influence BPD incidence.
Averages for days hospitalized and weight gain for
the NB with and without BPD were: 78.8±26.67 versus
43.0±14.49 days (p < 0.01) and 13.3±6.12 versus
18.5±4.25 g/kg/day (p < 0.01), respectively. This
association was maintained when the regression model
was used to exclude the confounding variables, BW and
GA (p < 0.01). The period of mechanical ventilation was
significantly shorter for NB without BPD compared with
NB with BPD 3.7±3.02 as against 27.2±21.26 days,
respectively (p < 0.01). At 28 days of life, 7/33 (212%)
of the NB in the BPD group had died and none had died
in the group without BPD (p < 0.00005).
Maternal and neonatal factors affecting the incidence... – Cunha GS et alii
Jornal de Pediatria - Vol. 79, Nº6, 2003  553
Discussion
As a result of its status as a tertiary center of excellence,
the CAISM concentrates a large proportion of the obstetric
and neonatal risk of the city of Campinas and the surrounding
region. These characteristics explain the elevated incidence
of VLBWI (4.3% - 213/4,897) observed during the period
under study.
In a recent prospective study the incidence of BPD
defined by the need for O2 at 28 days in VLBWI was 23%
and 62% for those whose BW was < 1,000 g,21while, in our
study, these values were 26.6 and 71%, respectively.
The findings of this study confirm expectations to the
extent that it confirmed that more premature and lower BW
were the independent factors most strongly associated with
the incidence of BPD. This data emphasizes that BPD as a
complication of prematurity will continue to be a common
cause of morbidity and a significant public health problem
since the rates of VLBWI survival continue to rise.
In contrast with previous studies,11,22 we did not find
as association between first and fifth minute Apgar
scores below 7 and BPD. These studies, however,
presented serious methodological problems. It should
also be pointed out that a premature NB may have a low
Apgar score because of its neurological development.
This fact may explain the result of our research that
suggests that an association between the fifth minute
Apgar score and BPD was confounded by BW and GA.
A number of different authors relate BPD with
DMH.12,23 The absence of a direct association between
HMD and BPD when IRR was adjusted for BW and GA
in these results attracts attention. Knowing that these two
variables constitute an approximation of an expression
Table 1 - Ratio of incidence of BPD according to neonatal variables
n BPD IR Whole RIR Adjusted RIR
(%) (95% CI) (95% CI)
Gestational age
> 3 weeks 86 12 14.0 ref.
< 30 weeks 38 21 55.3 4.0 (2.1-7.2)
Birthweight
> 1.000 g 93 11 11.8 ref.
750 - 1,000 g 27 18 66.7 5.6 (3.0-10.4)
< 750 g 4 4 100 8.4 (4.8-14.7)
Sex
Female 61 14 23.0 ref.
Male 63 19 30.2 1.3 (0.7-2.4)
Weight/age adjustment
SGA 64 16 25.0 ref.
AGA 60 17 28.3 1.1 (0.6-2.0)
Apgar index
1 min
> 7 54 11 20.4 ref. ref.
< 7 70 22 31.4 1.5 (0.8-2.9) 1.0 (0.4-2.3)
5 min
> 7 109 25 22.9 ref. ref.
< 7 15 8 53.3 2.3 (1.3-4.1) 1.1 (0.4-2.6)
Type of respiratory disorders
Others 27 4 14.8 ref. ref.
HMD 28 20 71.4 4.8 (1.8-12.2) 2.1 (0.6-6.7)
n: number of children; IR: incidence rate; RIR: ratio of incidence rate; ref.: reference; CI: confidence interval; BPD: bronchopulmonary
displasia; HMD: hyaline membrane disease; SGA: small for gestational age; AGA: adequate for gestational age.
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of the level of prematurity, the results permit the inference
that association with them eliminates any independent
effect in the genesis of BPD, thus remaining BW and GA
as the greatest determinants of BPD in NB that develop
HMD; a fact that is confirmed by the majority of work to
be found in literature published to date.
Our findings in terms of the prenatal use of corticoid
agree with the extensive meta-analysis by Crowley,24 but
are in contrast with a study by van Marter et al.13 In the
current study, those mothers who did not receive treatment
were those whose delivery was vaginal, who were admitted
at an advanced stage of labor and gave birth to NB with
lower BW and GA. This immaturity could have predisposed
them to develop BPD.
In relation to HDP, results are conflicting. Kim et
al.25 found a lower incidence of BPD (11% versus 58%,
p < 0.04) for NB whose mothers had moderate HDP
compared to NB whose mothers had severe HDP
(preeclampsia). It was shown that initially HDP behaved
in a protective manner against the incidence of BPD,
which could reflect a less severe disease in which NB are
Table 2 - Ratio of incidence rate for BPD according to maternal variables
n BPD IR Whole RIR Adjusted RIR
(%) (95% CI) (95% CI)
Prenatal corticoid
Yes 110 26 23.6 ref. ref.
No 13* 7 53.9 2.3 (1.2 - 4.2) 1.5 (0.6 - 3.6)
HDP
Yes 55 8 14.6 ref. ref.
No 69 25 36.2 0.4 (0.1 - 0.8) 0.4 (0.2 - 1.1)
Type of delivery
Vaginal 30 14 46.7 ref. ref.
Cesarean 94 19 20.2 0.4 (0.2 - 0.7) 1.1 (0.4 - 3.3)
Mother’s age
> 19 years 103 20 19.4 ref. ref.
< 19 years 21 13 61.9 3.2 (1.9 - 5.3) 1.7 (0.7 - 3.7)
Prenatal care
Yes 119 31 26.1 ref.
No 5 2 40.0 1.5 (0.5 - 4.7)
Number of prenatal consultations
> 3 82 19 23.2 ref.
< 3 42 14 33.3 1.4 (0.8 - 2.6)
n: number of children; IR: incidence interval; RIR: ratio of incidence rate; ref.: reference; CI: confidence interval; BPD:
bronchopulmonary displasia; HDP: hypertensive disorders of pregnancy; *1 ignored case
more mature and there is a lower incidence of BPD.
However, when confounding variables were controlled,
the protective effect remained, but was no longer
statistically significant. In a more detailed analysis it was
found that all of the mothers whose children developed
BPD had presented preeclampsia, and, due to
compromised fetal or maternal conditions, the pregnancy
had been interrupted, increasing prematurity and,
consequentially, the risk of BPD.
In this study the protective effect of caesarian
deliveries can be explained by the choice of this type of
delivery because of diagnoses of maternal or fetal
complications that may correlate with a more rigorous
control of the pregnancy. This having been known to be
the case, these mothers were better monitored and it was
possible to use corticoid and/or other measures in order
to prolong gestation and deliver their NB with greater
GA and BW. Indeed, the type of delivery did not influence
BPD incidence when controlled by BW and GA.
The greatest morbidity with NB is associated with
neonatal care, which can be measured in terms of period
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of hospitalization.14 There is an association between
average hospitalization durations and the presence of
BPD; it is significantly longer among NB with BPD.22
Rationally, it is to be expected that younger GA and also
low BW would be factors leading to increased NB
hospitalization periods.14 Notwithstanding, it became
clear that, excluding both GA and BW, BPD was
responsible for increasing the hospital stays of these NB.
As has been demonstrated by Korhonen et al.12 our
NB with BPD require significantly more time on
mechanical ventilation than NB without BPD. The
mortality of the group of NB with BPD was 21.2%. These
results are similar to those published by Hakulinen et
al.22 who found 22.8% among VLBWI with BPD and by
Farstad & Bratlid23 who published 17.4% and above
those of Kornhauser et al.26 who found 11%. However,
in this last study, the NB had higher GA, a fact that
greatly reduced mortality. In the present population, all
deaths occurred in the group of NB with BPD.
The results of this study allow for the conclusion that
the most effective means of reducing the incidence of
BPD is to reduce the incidence of prematurity. Prospective
work, involving risk factors should be stimulated as it
reaps benefits in terms of improved health for specific
populations. However, such work should concern itself
with assessing confounding variables to check the
independent contribution of each of the risk factors.
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